Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell
August 12, 2026
AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell
August 3, 2026
Notice To Annual General Meeting in AlzeCure Pharma AB
May 26, 2026
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 19, 2026
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 13, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 13, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 5, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
May 5, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
May 3, 2026
1
2
Next Page
→